These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7429002)

  • 1. Binding of erythromycin base to human plasma proteins.
    Prandota J; Tillement JP; d'Athis P; Campos H; Barre J
    J Int Med Res; 1980; 8 Suppl 2():1-8. PubMed ID: 7429002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of bornaprolol to human serum proteins and blood cells.
    Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
    Brunner F; Zini R; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
    Plum A; Müller LK; Jansen JA
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
    Albengres E; Urien S; Kusmierek J; Tillement JP
    Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine blood protein binding: influence of protein, pH and species.
    Owens SM; Mayersohn M; Woodworth JR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective plasma protein binding of amlodipine.
    Maddi S; Yamsani MR; Seeling A; Scriba GK
    Chirality; 2010 Feb; 22(2):262-6. PubMed ID: 19496159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs.
    Decroix MO; Zini R; Chaumeil JC; Tillement JP
    Biochem Pharmacol; 1988 Jul; 37(14):2807-14. PubMed ID: 3395358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.
    Hamberger C; Barre J; Zini R; Taiclet A; Houin G; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(6):441-9. PubMed ID: 3468088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
    Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
    McDonnell PA; Caldwell GW; Masucci JA
    Electrophoresis; 1998 Mar; 19(3):448-54. PubMed ID: 9551800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
    Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
    Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization of propofol binding to plasma proteins and possible interactions].
    Garrido MJ; Jiménez RM; Rodríguez-Sasiaín JM; Aguirre C; Aguilera L; Calvo R
    Rev Esp Anestesiol Reanim; 1994; 41(6):308-12. PubMed ID: 7838996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.